Aspira Pathlab & Diagnostics informs about delisting

30 Mar 2018 Evaluate

Aspira Pathlab & Diagnostics has informed that the Company will be delisted from the MSE with effect from April 12, 2018

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.03 2.03 (3.83%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.